The scope of clinical pharmacy practice and research has expanded to encompass behavioural, economic and humanistic dimensions alongside clinical responsibilities. The influence of behaviour on the efficacy of clinical services justifies the application of behaviour change theories to clinical pharmacy and practice research. This facilitates a deeper understanding of human behaviour in relation to health interventions and the provision of clinical pharmacy services. This commentary provides a summary of key concepts that researchers need to consider when using behavioural and/or social theories to underpin their research, outlining: (1) why this is important to support development of the pharmacist's role in patient care; (2) definitions of theories, models and frameworks; (3) a description of the UK Medical Research Council Framework; (4) an overview of the most commonly used behavioural theories, models and frameworks (supplemented by implementation, communication and other relevant humanistic and social theories); (5) lessons for clinical pharmacy and pharmacy practice researches. The comment aims to assist pharmacy practice and health research colleagues to improve the quality and rigour of theory underpinned research. The guidance in this paper is part of the commitment of the European Society of Clinical Pharmacy to stimulate innovative and high-quality research in all areas of clinical pharmacy.

• Klíčová slova
• Behavioural theory, Clinical pharmacy, Evidence-based pharmacy practice, Pharmacy research, Social pharmacy,
• Publikační typ
• dopisy MeSH

INTRODUCTION: It is important for health professional societies to involve members in defining their roles and future activities including research priorities. AIM: This study aimed to identify members' views on the areas of research that European Society of Clinical Pharmacy (ESCP) should prioritise in delivering research support, research projects and education. METHOD: An online questionnaire was initially developed by the ESCP Research Committee and reviewed by the research team. It included structured and open-ended items related to respondents' demographics, research experience, views on future research priorities, topics that ESCP should prioritise, and barriers to research involvement. After testing face and content validity, the questionnaire was sent to all ESCP members (N = 417). Descriptive statistics and summative content analysis were used. RESULTS: Eighty-two responses were received (response rate: 19.7%). Research on real-world processes that facilitate the implementation of clinical pharmacy services into every-day practice was the priority for most respondents (n = 77, 93.9%). Respondents believed that ESCP should focus on research support for implementation science (n = 52, 63.4%) and methods to analyse clinical judgement and decision-making (n = 48, 58.5%). The perceived barriers to developing high-quality research in clinical pharmacy were reported as a lack of knowledge, skills and training, limited funding opportunities and insufficient time. CONCLUSION: Research topics identified will help to inform ESCP and its committees on the priorities for research activities of the society in the near future, as well as other collaborating professional organisations of the current priority research objectives of ESCP in the international context.

• Klíčová slova
• Barriers, Clinical pharmacist, European Society of Clinical Pharmacy, Research priorities,
• Publikační typ
• časopisecké články MeSH

• Publikační typ
• úvodníky MeSH